ADIM
OHI icon

Alpha DNA Investment Management’s Omega Healthcare OHI Stock Holding History

Alpha DNA Investment Management’s Portfolio OHI Stock Details OHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,991
Closed -$454K – 119
2024
Q4 		$454K Buy
+11,991
New +$479K 0.17% 129

Other funds holding OHI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alpha DNA Investment Management's OHI Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Omega Healthcare (OHI) in Q1 2025, closing a stake of 11,991 shares — an estimated $454K sold.

Alpha DNA Investment Management first reported a position in OHI in Q4 2024 and held it in 1 quarter. The position peaked at $454K in Q4 2024. 621 funds tracked by Wall St. Rank hold OHI as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Omega Healthcare position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 11,991 Omega Healthcare shares in Q1 2025, an estimated $454K.
  • Alpha DNA Investment Management first reported a position in Omega Healthcare in Q4 2024 and held it in 1 quarter.
  • Alpha DNA Investment Management's Omega Healthcare position peaked at $454K in Q4 2024.
  • 621 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.